Z85.810: Personal history of malignant neoplasm of tongue
Z85.810, personal history of malignant neoplasm of tongue, is listed as a covered diagnosis in 3 Medicare billing and coding articles that apply to 15 HCPCS Level II codes, including J9267 (Injection, paclitaxel, 1 mg), J9264 (Injection, paclitaxel protein-bound particles, 1 mg), J0461 (Injection, atropine sulfate, 0.01 mg). The articles come from 3 Medicare contractors. A listed diagnosis supports medical necessity only; coverage still depends on the LCD's criteria and on documentation in the medical record.
HCPCS Level II codes with Z85.810 as a covered diagnosis
| Code | Description | Medicare coverage | DMEPOS fee 2026 (state range) | Articles listing it |
|---|---|---|---|---|
| J9267 | Injection, paclitaxel, 1 mg | Special coverage instructions apply | — | 1 |
| J9264 | Injection, paclitaxel protein-bound particles, 1 mg | Carrier judgment | — | 1 |
| J0461 | Injection, atropine sulfate, 0.01 mg | Special coverage instructions apply | — | 1 |
| J0153 | Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | Special coverage instructions apply | — | 1 |
| J1250 | Injection, dobutamine hydrochloride, per 250 mg | Special coverage instructions apply | — | 1 |
| J0280 | Injection, aminophyllin, up to 250 mg | Special coverage instructions apply | — | 1 |
| J1245 | Injection, dipyridamole, per 10 mg | Special coverage instructions apply | — | 1 |
| J8999 | Prescription drug, oral, chemotherapeutic, nos | Special coverage instructions apply | — | 1 |
| Q0512 | Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period | Special coverage instructions apply | — | 1 |
| Q0511 | Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period | Special coverage instructions apply | — | 1 |
| J8530 | Cyclophosphamide; oral, 25 mg | Special coverage instructions apply | — | 1 |
| J8597 | Antiemetic drug, oral, not otherwise specified | Special coverage instructions apply | — | 1 |
| J8610 | Methotrexate; oral, 2.5 mg | Special coverage instructions apply | — | 1 |
| J8498 | Antiemetic drug, rectal/suppository, not otherwise specified | Special coverage instructions apply | — | 1 |
| A9270 | Non-covered item or service | Non-covered by Medicare | Not covered | 1 |
Medicare policy articles listing Z85.810
- A52450: Billing and Coding: Paclitaxel (e.g., Taxol®/Abraxane ™) (Wellpoint Federal (MAC - Part A, MAC - Part B); 2 Level II codes)
- A54768: Billing and Coding: Cardiac Blood Pool Imaging (Multiple Gated Acquisition Scanning- MUGA, Ventriculography) When Performed in Conjunction with Cardiotoxic Chemotherapy (Palmetto GBA (MAC - Part A, MAC - Part B); 5 Level II codes)
- A52479: Oral Anticancer Drugs - Policy Article (CGS Administrators, LLC (DME MAC) Noridian Healthcare Solutions, LLC (DME MAC); 8 Level II codes). LCD with the same title: L33826
A diagnosis listed as covered in a billing and coding article supports medical necessity for the article's codes; it does not guarantee payment. Coverage depends on the LCD's criteria, the contractor's jurisdiction and documentation in the medical record.
Other Z85 diagnoses (Personal history of malignant neoplasm)
- Z85.818 — Personal history of malignant neoplasm of other sites of lip, oral…
- Z85.819 — Personal history of malignant neoplasm of unspecified site of lip…
- Z85.820 — Personal history of malignant melanoma of skin
- Z85.831 — Personal history of malignant neoplasm of soft tissue
- Z85.841 — Personal history of malignant neoplasm of brain
- Z85.89 — Personal history of malignant neoplasm of other organs and systems
- Z85.00 — Personal history of malignant neoplasm of unspecified digestive organ
- Z85.01 — Personal history of malignant neoplasm of esophagus
- Z85.028 — Personal history of other malignant neoplasm of stomach
- Z85.038 — Personal history of other malignant neoplasm of large intestine
- Z85.048 — Personal history of other malignant neoplasm of rectum, rectosigmoid…
- Z85.05 — Personal history of malignant neoplasm of liver
- Z85.068 — Personal history of other malignant neoplasm of small intestine
- Z85.07 — Personal history of malignant neoplasm of pancreas
- Z85.09 — Personal history of malignant neoplasm of other digestive organs
- Z85.118 — Personal history of other malignant neoplasm of bronchus and lung
- Z85.21 — Personal history of malignant neoplasm of larynx
- Z85.22 — Personal history of malignant neoplasm of nasal cavities, middle…
- Z85.3 — Personal history of malignant neoplasm of breast
- Z85.41 — Personal history of malignant neoplasm of cervix uteri
- Z85.42 — Personal history of malignant neoplasm of other parts of uterus
- Z85.43 — Personal history of malignant neoplasm of ovary
- Z85.44 — Personal history of malignant neoplasm of other female genital organs
- Z85.46 — Personal history of malignant neoplasm of prostate
- Z85.47 — Personal history of malignant neoplasm of testis
- Z85.49 — Personal history of malignant neoplasm of other male genital organs
- Z85.4A — Personal history of malignant neoplasm of fallopian tube(s)
- Z85.51 — Personal history of malignant neoplasm of bladder
- Z85.528 — Personal history of other malignant neoplasm of kidney
- Z85.53 — Personal history of malignant neoplasm of renal pelvis
Frequently asked questions
Does Medicare cover Z85.810 (Personal history of malignant neoplasm of tongue)?
Medicare covers items and services, not diagnoses. 3 Medicare billing and coding articles list Z85.810 as a covered diagnosis for 15 HCPCS Level II codes: the diagnosis can support medical necessity for those codes, but payment still depends on the LCD's coverage criteria and the medical record.
Which HCPCS codes can be billed with ICD-10 Z85.810?
The Level II codes from the policies most specific to this diagnosis are J9267 (Injection, paclitaxel, 1 mg, 1 article); J9264 (Injection, paclitaxel protein-bound particles, 1 mg, 1 article); J0461 (Injection, atropine sulfate, 0.01 mg, 1 article); J0153 (Injection, adenosine, 1 mg (not to be used to report any…, 1 article); J1250 (Injection, dobutamine hydrochloride, per 250 mg, 1 article). Code choice depends on the item supplied; check each code's descriptor.
Which Medicare policy articles list Z85.810?
A52450 (Billing and Coding: Paclitaxel (e.g., Taxol®/Abraxane ™)); A54768 (Billing and Coding: Cardiac Blood Pool Imaging (Multiple Gated Acquisition Scanning- MUGA, Ventriculography) When Performed in Conjunction with Cardiotoxic Chemotherapy); A52479 (Oral Anticancer Drugs - Policy Article).
What is ICD-10-CM code Z85.810?
Z85.810 is the ICD-10-CM code for personal history of malignant neoplasm of tongue, in category Z85 (Personal history of malignant neoplasm), chapter 22: Factors influencing health status and contact with health services.
Next steps
- Run a reimbursement report for a device billed under J9267
- Watch J9267 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J9267
Sources: CMS Medicare Coverage Database billing and coding articles (covered ICD-10 code lists and HCPCS links); ICD-10-CM FY2026; CMS HCPCS Level II release October 2026; CMS DMEPOS fee schedule 2026 (non-rural state fees). Not billing or legal advice.
Chapter 22: Factors influencing health status and contact with health services · All diagnoses · HCPCS lookup